Helius Short Long Term Debt from 2010 to 2024

HSDT Stock

USD 0.45 0.02 4.65%

Helius Medical Short and Long Term Debt yearly trend continues to be comparatively stable with very little volatility. Short and Long Term Debt is likely to outpace its year average in 2024. Short and Long Term Debt is the total of a company's short-term and long-term borrowings. View All Fundamentals

Short and Long Term Debt

First Reported

2010-12-31

Previous Quarter

11 M

Current Value

11.6 M

Quarterly Volatility

4.4 M

Credit Downgrade

Yuan Drop

Covid

Check Helius Medical financial statements over time to gain insight into future company performance. You can evaluate financial statements to find patterns among Helius Medical's main balance sheet or income statement drivers, such as Interest Expense of 244.2 K, Selling General Administrative of 9.6 M or Other Operating Expenses of 16.1 M, as well as many indicators such as Price To Sales Ratio of 7.21, Dividend Yield of 0.0 or PTB Ratio of 2.18. Helius financial statements analysis is a perfect complement when working with Helius Medical Valuation or Volatility modules.

Check out the analysis of Helius Medical Correlation against competitors.

Latest Helius Medical's Short Long Term Debt Growth Pattern

Below is the plot of the Short Long Term Debt of Helius Medical Technologies over the last few years. It is the total of a company's short-term and long-term borrowings. Helius Medical's Short and Long Term Debt historical data analysis aims to capture in quantitative terms the overall pattern of either growth or decline in Helius Medical's overall financial position and show how it may be relating to other accounts over time.

Short Long Term Debt

10 Years Trend

Slightly volatile

Compare to Others All Fundamentals

Short Long Term Debt

Timeline

Helius Short Long Term Debt Regression Statistics

	Arithmetic Mean	6,329,482
	Geometric Mean	3,525,535
	Coefficient Of Variation	68.76
	Mean Deviation	3,921,637
	Median	9,578,000
	Standard Deviation	4,352,077
	Sample Variance	18.9T
	Range	11.2M
	R-Value	0.94
	Mean Square Error	2.4T
	R-Squared	0.88
	Slope	913,485
	Total Sum of Squares	265.2T

Helius Short Long Term Debt History

	2024	11.6 M
	2023	11 M
	2017	9.6 M
	2014	4.5 M

Other Fundumenentals of Helius Medical Techn

Short Long Term Debt Total

Helius Medical Short Long Term Debt component correlations

	Total Assets	Total Stockholder Equity	Net Tangible Assets	Net Debt	Retained Earnings	Accounts Payable	Total Liab	Short Long Term Debt	Total Current Assets	Short Term Debt	Common Stock	Long Term Debt	Net Receivables	Short Term Investments	Capital Surpluse	Deferred Long Term Liab	Current Deferred Revenue	Net Invested Capital	Net Working Capital	Property Plant Equipment	Capital Stock	Good Will	Intangible Assets
Total Assets		0.74	0.7	-0.98	-0.68	0.35	0.77	0.71	0.99	0.53	-0.18	0.45	0.42	-0.09	0.69	0.45	0.11	0.86	0.84	0.51	-0.14	-0.34	-0.33
Total Stockholder Equity	0.74		0.89	-0.69	-0.62	-0.23	0.14	0.45	0.71	0.17	-0.7	0.24	0.03	-0.04	0.74	0.24	0.02	0.91	0.86	0.56	-0.3	-0.39	-0.37
Net Tangible Assets	0.7	0.89		-0.62	-0.79	-0.32	0.19	0.6	0.68	0.09	-0.7	0.55	0.2	-0.47	0.89	0.55	-0.28	0.87	0.9	0.56	-0.57	-0.69	-0.7
Net Debt	-0.98	-0.69	-0.62		0.55	-0.36	-0.79	-0.59	-0.99	-0.62	0.14	-0.35	-0.31	-0.01	-0.56	-0.35	-0.13	-0.77	-0.76	-0.35	0.04	0.25	0.24
Retained Earnings	-0.68	-0.62	-0.79	0.55		-0.01	-0.41	-0.92	-0.64	0.13	0.27	-0.81	-0.64	0.52	-0.96	-0.81	0.4	-0.85	-0.9	-0.63	0.66	0.83	0.8
Accounts Payable	0.35	-0.23	-0.32	-0.36	-0.01		0.73	0.36	0.35	0.52	0.8	0.2	0.57	0.25	-0.13	0.2	0.41	0.01	-0.08	0.05	0.29	0.35	0.33
Total Liab	0.77	0.14	0.19	-0.79	-0.41	0.73		0.63	0.8	0.62	0.39	0.43	0.58	-0.09	0.31	0.43	0.14	0.4	0.42	0.22	0.08	-0.14	-0.14
Short Long Term Debt	0.71	0.45	0.6	-0.59	-0.92	0.36	0.63		0.68	0.07	0.04	0.8	0.78	-0.44	0.85	0.8	-0.19	0.76	0.77	0.63	-0.54	-0.63	-0.61
Total Current Assets	0.99	0.71	0.68	-0.99	-0.64	0.35	0.8	0.68		0.57	-0.15	0.44	0.39	-0.1	0.64	0.44	0.07	0.81	0.81	0.42	-0.11	-0.34	-0.34
Short Term Debt	0.53	0.17	0.09	-0.62	0.13	0.52	0.62	0.07	0.57		0.15	-0.01	-0.05	0.2	-0.07	-0.01	0.51	0.14	0.06	-0.04	0.3	0.34	0.32
Common Stock	-0.18	-0.7	-0.7	0.14	0.27	0.8	0.39	0.04	-0.15	0.15		0.03	0.37	0.2	-0.48	0.03	0.07	-0.48	-0.47	-0.38	0.29	0.34	0.32
Long Term Debt	0.45	0.24	0.55	-0.35	-0.81	0.2	0.43	0.8	0.44	-0.01	0.03		0.8	-0.6	0.72	1.0	-0.39	0.5	0.57	0.45	-0.62	-0.7	-0.73
Net Receivables	0.42	0.03	0.2	-0.31	-0.64	0.57	0.58	0.78	0.39	-0.05	0.37	0.8		-0.33	0.49	0.8	-0.12	0.37	0.39	0.52	-0.24	-0.39	-0.41
Short Term Investments	-0.09	-0.04	-0.47	-0.01	0.52	0.25	-0.09	-0.44	-0.1	0.2	0.2	-0.6	-0.33		-0.52	-0.6	0.56	-0.17	-0.3	-0.26	0.63	0.7	0.77
Capital Surpluse	0.69	0.74	0.89	-0.56	-0.96	-0.13	0.31	0.85	0.64	-0.07	-0.48	0.72	0.49	-0.52		0.72	-0.27	0.9	0.92	0.72	-0.67	-0.77	-0.74
Deferred Long Term Liab	0.45	0.24	0.55	-0.35	-0.81	0.2	0.43	0.8	0.44	-0.01	0.03	1.0	0.8	-0.6	0.72		-0.39	0.5	0.57	0.45	-0.62	-0.7	-0.73
Current Deferred Revenue	0.11	0.02	-0.28	-0.13	0.4	0.41	0.14	-0.19	0.07	0.51	0.07	-0.39	-0.12	0.56	-0.27	-0.39		-0.04	-0.27	0.25	0.49	0.8	0.82
Net Invested Capital	0.86	0.91	0.87	-0.77	-0.85	0.01	0.4	0.76	0.81	0.14	-0.48	0.5	0.37	-0.17	0.9	0.5	-0.04		0.96	0.69	-0.43	-0.53	-0.5
Net Working Capital	0.84	0.86	0.9	-0.76	-0.9	-0.08	0.42	0.77	0.81	0.06	-0.47	0.57	0.39	-0.3	0.92	0.57	-0.27	0.96		0.61	-0.44	-0.71	-0.68
Property Plant Equipment	0.51	0.56	0.56	-0.35	-0.63	0.05	0.22	0.63	0.42	-0.04	-0.38	0.45	0.52	-0.26	0.72	0.45	0.25	0.69	0.61		-0.17	-0.29	-0.28
Capital Stock	-0.14	-0.3	-0.57	0.04	0.66	0.29	0.08	-0.54	-0.11	0.3	0.29	-0.62	-0.24	0.63	-0.67	-0.62	0.49	-0.43	-0.44	-0.17		0.66	0.65
Good Will	-0.34	-0.39	-0.69	0.25	0.83	0.35	-0.14	-0.63	-0.34	0.34	0.34	-0.7	-0.39	0.7	-0.77	-0.7	0.8	-0.53	-0.71	-0.29	0.66		0.97
Intangible Assets	-0.33	-0.37	-0.7	0.24	0.8	0.33	-0.14	-0.61	-0.34	0.32	0.32	-0.73	-0.41	0.77	-0.74	-0.73	0.82	-0.5	-0.68	-0.28	0.65	0.97

Click cells to compare fundamentals

About Helius Medical Financial Statements

Helius Medical shareholders use historical fundamental indicators, such as Short Long Term Debt, to determine how well the company is positioned to perform in the future. Although Helius Medical investors may analyze each financial statement separately, they are all interrelated. The changes in Helius Medical's assets and liabilities, for example, are also reflected in the revenues and expenses on on Helius Medical's income statement. Understanding these patterns can help investors time the market effectively. Please read more on our fundamental analysis page.

	Last Reported	Projected for Next Year
Short and Long Term Debt	11 M	11.6 M
Short and Long Term Debt Total	57 K	54.1 K

Thematic Opportunities

Explore Investment Opportunities

Build portfolios using Macroaxis predefined set of investing ideas. Many of Macroaxis investing ideas can easily outperform a given market. Ideas can also be optimized per your risk profile before portfolio origination is invoked. Macroaxis thematic optimization helps investors identify companies most likely to benefit from changes or shifts in various micro-economic or local macro-level trends. Originating optimal thematic portfolios involves aligning investors' personal views, ideas, and beliefs with their actual investments.

Explore Investing Ideas

Additional Tools for Helius Stock Analysis

When running Helius Medical's price analysis, check to measure Helius Medical's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Helius Medical is operating at the current time. Most of Helius Medical's value examination focuses on studying past and present price action to predict the probability of Helius Medical's future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Helius Medical's price. Additionally, you may evaluate how the addition of Helius Medical to your portfolios can decrease your overall portfolio volatility.

Macroaxis helps investors of all levels and skills to maximize the upside of all their holdings and minimize the risk associated with market volatility, economic swings, and company-specific events. View terms and conditions

Feedback Blog

Made with optimal in San Francisco

2024 Macroaxis LLC